Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
4.56M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
47M
-
Shares change
-
+47M
-
Total reported value, excl. options
-
$1.71B
-
Value change
-
+$1.71B
-
Number of buys
-
74
-
Price
-
$36.50
Significant Holders of RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX) as of Q2 2021
77 filings reported holding RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock as of Q2 2021.
RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47M shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (18.5M shares), Laurion Capital Management LP (3.86M shares), VANGUARD GROUP INC (2.68M shares), ARK Investment Management LLC (2.38M shares), FMR LLC (2.21M shares), HARVARD MANAGEMENT CO INC (1.51M shares), CREDIT SUISSE AG/ (1.45M shares), BlackRock Inc. (1.44M shares), MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC (1.39M shares), and ALLIANCEBERNSTEIN L.P. (1.3M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.